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The Arabidopsis protein RPM1 activates disease resist-
ance in response to Pseudomonas syringae proteins
targeted to the inside of the host cell via the bacterial
type III delivery system. We demonstrate that speci®c
mutations in the ATP-binding domain of a single
Arabidopsis cytosolic HSP90 isoform compromise
RPM1 function. These mutations do not affect the
function of related disease resistance proteins. RPM1
associates with HSP90 in plant cells. The Arabidopsis
proteins RAR1 and SGT1 are required for the action
of many R proteins, and display some structural
similarity to HSP90 co-chaperones. Each associates
with HSP90 in plant cells. Our data suggest that
(i) RPM1 is an HSP90 client protein; and (ii) RAR1
and SGT1 may function independently as HSP90
cofactors. Dynamic interactions among these proteins
can regulate RPM1 stability and function, perhaps




Our understanding of disease resistance speci®city in
plants centers on the structure and function of pathogen-
speci®c Resistance (R) gene products. R proteins confer
resistance to pathogen strains expressing a molecule that
speci®cally triggers its action (Dangl and Jones, 2001).
The largest class of R protein contains a nucleotide-
binding site (NB) and leucine-rich repeats (LRRs), and are
termed NB-LRRs (Dangl and Jones, 2001). The repertoire
of R proteins, though deployed with broad population
polymorphism, may still not be suf®ciently diverse to
mediate direct recognition of all relevant pathogens. The
question of repertoire size, among others, drove the
formulation of the `guard hypothesis'. Here, pathogen
molecules that trigger R action are most easily thought of
as virulence factors whose presence is sensed by the host
cell. Experimental evidence supports this model, though it
is not yet fully generalizable (Dangl and Jones, 2001; Holt
et al., 2003). NB-LRR activation may include a large
conformational change, perhaps akin to the `jackknife
model' leading to proximity-induced activation as pro-
posed for Apaf-1 (Moffett et al., 2002; Hwang and
Williamson, 2003). This, in turn, leads to a series of
cellular events that collectively form the defense response
(Holt et al., 2003). It is unclear what portion of this diverse
defense response is actually required to halt pathogen
growth.
Arabidopsis RPM1 is an NB-LRR protein that confers
recognition to bacterial strains expressing either of two
divergent type III effector genes, avrRpm1 or avrB (Grant
et al., 1995). These two type III effector proteins have
virulence function on hosts lacking RPM1 (rpm1; disease
susceptible; Ash®eld et al., 1995; Ritter and Dangl, 1995).
Recognition of AvrRpm1 or AvrB by RPM1 may be the
consequence of their action on Arabidopsis RIN4 (RPM1-
interacting protein 4). RIN4 is a protein of unknown
function and is phosphorylated in response to the presence
of either AvrRpm1 or AvrB (Mackey et al., 2002). RIN4
can interact with RPM1, AvrRpm1 and AvrB in vivo. All
four of these proteins localize to the plasma membrane
(Boyes et al., 1998; Nimchuk et al., 2000; Mackey et al.,
2002).
A limited set of genetically de®ned proteins are broadly
required for the action of Arabidopsis R gene subsets
(Dangl and Jones, 2001). The ndr1 mutation compromises
the function of a subset of NB-LRR R proteins (Century
et al., 1997). NDR1 is a putative glycosylphosphatidyli-
nositol (GPI)-anchored protein (B.Staskawicz, personal
communication). Mutations in RAR1 and SGT1b, one of
two SGT1 orthologs in Arabidopsis, compromise the
function of many R proteins (Azevedo et al., 2002;
Muskett et al., 2002; ToÈr et al., 2002; Tornero et al.,
2002b). Plant SGT1 proteins share similarity with the
yeast SGT1 protein, a regulator of the SCF ubiquitin ligase
complexes in a variety of cellular processes (Kitigawa
et al., 1999). RAR1 and SGT1 can interact in vivo, and
presumably function together (Azevedo et al., 2002).
RPM1 function is compromised by ndr1 and by rar1
but, surprisingly, is not compromised by either sgt1a or
sgt1b. Because an sgt1a/sgt1b double mutant is lethal
(A.Takahashi and K.Shirasu, in preparation), overlapping
contributions of these genes to RPM1 function cannot be
determined. We performed a large-scale screen for loss of
RPM1-mediated hypersensitive cell death (hypersensitive
response; HR) in response to conditional expression of an
avrRpm1 transgene (Tornero et al., 2002a). We describe
here four mutant alleles of the Arabidopsis HSP90.2 gene
that caused loss of RPM1-speci®ed HR and disease
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resistance in that screen. This represents the ®rst
phenotype attributed to mutation of a plant cytosolic
HSP90.
We demonstrate that RPM1 is the ®rst client protein
described for plant cytosolic HSP90, using as criteria
(i) in vivo HSP90±RPM1 interaction; (ii) modulation of
RPM1 function by particular mutant alleles of the
HSP90.2 isoform; and (iii) greatly decreased steady-state
RPM1 levels in these hsp90.2 mutant backgrounds. We
describe genetic interactions between HSP90.2 and both
RPM1 and NDR1. We provide evidence for in vivo
interactions between HSP90s and both RAR1 and SGT1.
Thus, we describe a possible mechanism by which RAR1
and SGT1 affect disease resistance protein signaling
through probable cofactor interactions with cytosolic
HSP90s.
Results
lra2 mutations speci®cally affect RPM1-mediated
pathogen recognition
We screened ~500 000 ethyl methanesulfonate (EMS)-
mutagenized Arabidopsis M2 individuals for mutants
affecting recognition of avrRpm1. Among others, we
identi®ed four allelic mutations that we called lra2-1,
lra2-2, lra2-3 and lra2-4 (lra2; loss of recognition of
avrRpm1; Tornero et al., 2002a). Two of these, independ-
ently isolated, were later found to carry the same mutation.
Both the lra2-2 and lra2-3 alleles have an intermediate
effect on RPM1 function (as did the other two alleles, data
not shown) measured by pathogen growth and disease
symptoms following challenge with Pseudomonas
syringae pv tomato (Pst) strain DC3000 expressing either
avrRpm1 or avrB (Figure 1; data not shown). We did not
see a signi®cant effect on other R genes active against
different type III effectors from P.syringae (Figure 1).
RPM1-mediated HR was also altered, but not completely
abolished, in the lra2 mutants in response to in®ltration
with Pst DC3000(avrRpm1). This is similar to the effect of
rar1 on RPM1-mediated HR (Tornero et al., 2002b).
While normal RPM1-mediated HR occurs 5±8 h after
inoculation, we observed a low frequency of HR on leaves
from all lra2 alleles by 20 h (data not shown). The effect of
lra2 mutations on the HR was also speci®c to RPM1.
Basal resistance against virulent pathogens (Pst
DC3000) was not signi®cantly affected (Figure 1). We
also observed no alteration in the responses of lra2 alleles
to infection with a series of Peronospora parasitica
isolates (Holub et al., 1994). This included isolates that
were either speci®cally recognized by various R genes in
the lra2 parental background [Cala2 (recognized by
RPP1a), Emoy2 (RPP4), Emwa1 (RPP4) and Hiks1
(RPP7)] or caused downy mildew disease (Emco5 and
Noco2) (data not shown).
We observed that lra2-2 and lra2-4 displayed a partial
penetrance phenotype for both HR and onset of disease
Fig. 1. Mutations in lra2 speci®cally affect RPM1 signaling. Growth of Pst DC3000 containing the indicated avirulence genes in lra2 mutants and
corresponding controls (used throughout). The a11 line is the Col-0 parent containing the estradiol-inducible avrRpm1 transgene (Tornero et al.,
2002a). The a11;rpm1-1 line is the a11 transgene crossed into an isogenic rpm1-1 background. Bacterial numbers here and in Figures 2 and 3 are
expressed as the log10 of c.f.u/mg fresh weight (f.w.) (Tornero and Dangl, 2001). Error bars indicate 6SE. Growth of Pst DC3000(vector) did not
show a signi®cant difference in growth in lra2 mutants. Pst DC3000(avrRpm1) and Pst DC3000(avrB) exhibited consistent increased growth in lra2
mutants intermediate to growth observed in rpm1 mutants in four independent experiments.
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symptoms. After inoculation with low doses of Pst
DC3000(avrRpm1), lra2-2 and lra2-4 plants either devel-
oped symptoms characteristic of disease (in 0±80% of
plants) or were completely asymptomatic (data not
shown). Progeny from self-fertilization of either sympto-
matic or asymptomatic individuals displayed similar
variable penetrance in the next generation (data not
shown). The partially penetrant disease phenotype did
not in¯uence the standard deviation in our bacterial growth
assays (see Figure 1).
LRA2 and RPM1 interact genetically
We made test cross F1s between rpm1 and all lra2 alleles
and assayed two phenotypes for allelism: the HR resulting
from estradiol induction of the avrRpm1 transgene
contained in these lines (Tornero et al., 2002a) and
bacterial symptoms resulting from Pst DC3000(avrRpm1)
infection. Both of these assays initially suggested that lra2
was allelic to rpm1 in the F1 generation. However, F2
progeny from these F1s contained a large percentage of
phenotypically wild-type individuals. This is inconsistent
with allelism, and is consistent with non-allelic non-
complementation. In this condition, F1 individuals of a
cross between two unlinked recessive mutants (each
mutation thus heterozygous) display a phenotype similar
to either homozygous single mutant. This often indicates
that the two genes act together, that the protein products
physically interact or are part of the same protein complex,
or that half the wild-type dose of the two, in combination,
is insuf®cient for wild-type function (e.g. Belanger et al.,
1994; Larkin et al., 1999).
We assayed HR response and bacterial growth in the
lra2 alleles and in various F1 progeny (Figure 2) to address
the apparent genetic interaction between LRA2 and RPM1.
The wild-type parental plant line, containing the estradiol-
inducible avrRpm1 transgene (called a11; Tornero et al.,
2002a) responded to estradiol with a strong HR
(Figure 2A). The isogenic a11;rpm1-1 control (Tornero
Fig. 2. LRA2 and RPM1 interact genetically. (A) Trypan blue staining of an HR assay following estradiol induction of avrRpm1 expression.
Two-week-old plants were treated with 10 mM estradiol with 0.02% silwet, and stained with trypan blue 2 days later. Row 1 displays parental
responses to conditional expression of avrRpm1. Row 2 displays that the lra2 and rpm1 mutants are recessive. Row 3 shows that rpm1;lra2
trans-heterozygotes do not express HR. Three independent repetitions were performed. (B) Growth of Pst DC3000(avrRpm1) in the same genotypes as
(A). Error bars indicate 6SE of triplicates from this experiment. The experiment was performed six times with similar results.
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et al., 2002a) and the tested lra2 alleles exhibited no HR.
The obvious induction of HR in F1 progeny of backcrosses
to a11 demonstrated that both rpm1 and the tested lra2
alleles were recessive in this assay. Strikingly, F1 progeny
of (a11;rpm1-1 3 lra2-2 or 3 lra2-3) did not respond to
estradiol (Figure 2A). Furthermore, lra2-2 and lra2-3
partially compromised RPM1 inhibition of bacterial
growth, and were fully recessive for this phenotype
when assayed as F1s backcrossed to the a11 parental line
(Figure 2B). The F1 progeny of (a11;rpm1-1 3 lra2-x)
exhibited modest, but reproducible, reduction of RPM1
function. These plants allowed bacterial growth between
that of the lra2 parent and the (a11 3 a11;rpm1-1) F1
control. This genetic interaction is speci®c to lra2 and
rpm1, as we did not observe non-allelic non-complemen-
tation in other trans-heterozygous combinations of mu-
tants affecting the RPM1 pathway tested (tested were
rar1 3 rpm1, ndr1 3 rpm1, rar1 3 ndr1, rar1 3 lra2 and
ndr1 3 lra2; data not shown). The data in Figure 2
strongly support the conclusion that rpm1 and lra2 exhibit
non-allelic non-complementation. Our data thus suggest
that the respective wild-type RPM1 and LRA2 proteins
work in the same pathway, and potentially interact
physically.
ndr1 and lra2 display both synergistic and
epistatic interactions
Like lra2, ndr1 supported an intermediate level of
bacterial growth when challenged with Pst
DC3000(avrRpm1) (Figure 3). Additionally, the RPM1-
mediated HR is severely attenuated in lra2 (see above), but
not compromised in ndr1 (Century et al., 1995; Tornero
et al., 2002b). These incomplete phenotypic effects
allowed us to assay for genetic interaction between lra2
and ndr1. We constructed lra2;ndr1 double mutants and
tested them for bacterial growth and HR. The lra2;ndr1
double mutants were completely compromised for RPM1
function, allowing as much pathogen growth as an rpm1
mutant following application of Pst DC3000(avrRpm1)
(Figure 3; note log scale). The lra2;ndr1 double mutant
also displayed full loss of Pst DC3000(avrRpm1)-trig-
gered HR, suggesting that LRA2 is required for the RPM1-
dependent HR remaining in ndr1 mutants. Note that while
the ndr1 allele is a null (Century et al., 1997), the lra2
mutants presented here are not (see below).
LRA2 is HSP90.2
We cloned LRA2 based on its map position. Our mapping
population of disease-susceptible (lra2;lra2) individuals
narrowed the LRA2 interval to an ~52 kb region on the
bottom arm of chromosome V (see Materials and methods
and Supplementary ®gure 1, available at The EMBO
Journal Online). We sequenced candidate genes from this
interval in the lra2-1 mutant and found a G/A transition at
position 21 937 (nucleotide positions relative to the
published sequence of P1 clone MDA7; GenBank acces-
sion No. AB011476). This created a G95E mutation in the
cytosolic HSP90.2 (At5g56030; Figure 4A). We se-
quenced this gene from the other three independently
isolated lra2 alleles and found mutations in lra2-2
(C21952T; S100F, independently isolated in lra2-4) and
in lra2-3 (G21785A; D80N) (Figure 4A). To avoid
confusion and to follow accepted nomenclature conven-
tions, we re-designate the lra2 alleles hsp90.2-1, hsp90.2-2
and hsp90.2-3 for lra2-1, lra2-2 and lra2-3, respectively.
All mutations were within the conserved ATPase
domain of this HSP90 (Figure 4A). The hsp90.2-3 change
(D80N; yellow in Figure 4B) alters a residue previously
shown to make multiple ATP contacts in the crystal
structure of yeast HSP90 (Prodromou et al., 1997). The
hsp90.2-1 (G95E) and hsp90.2-2 (S100F) changes are both
adjacent to residues that make direct contact with ATP
(N93 and R99). The G95E change should alter the local
charge density, while the S100F change results in addition
of a large hydrophobic side chain. We used molecular
markers based on the mutation to outcross hsp90.2-3 from
the conditional avrRpm1 expression transgenes (Materials
and methods). This line expressed the same signi®cant
reduction of RPM1 function as its parent line, measured by
both disease symptoms (Figure 5A, compare with Figure 1)
and pathogen growth (Figure 5B). Thus, the transgenes
carrying the estradiol-inducible avrRpm1 system have no
effect on the mutant phenotype. Finally, an insertion allele,
hsp90.2-5 (a T-DNA insertion at approximately nucleotide
23 453, amino acid position 601 of 699, SiGNAL line
SALK_058553; Supplementary ®gure 1) was viable and
exhibited no alteration of RPM1-mediated resistance
(Figure 5B). We did not detect a truncated form by
western blot (data not shown), and assume that this allele
is a null. We infer that one of the other three highly
homologous cytosolic HSP90s compensates for the loss of
HSP90.2 (Borkovich et al., 1989). HSP90.2 is constitu-
tively expressed, especially in ¯ower structures and roots
(Yabe et al., 1994). We observed only very modest
pleiotropic developmental changes in the hsp90.2 mutants
(Queitsch et al., 2002) (Supplementary ®gure 2). Thus, the
hsp90.2 alleles identi®ed in our screen are rare, speci®c,
and not compensated for by other HSP90 isoforms.
HSP90 associates with RPM1 in vivo
An RPM1-myc epitope-tagged protein is a peripheral
plasma membrane protein (Boyes et al., 1998), and fails to
accumulate in rar1 plants (Tornero et al., 2002b). We
crossed an RPM1-myc transgene (Boyes et al., 1998) into
both the fully penetrant hsp90.2-3 allele and the partially
penetrant hsp90.2-2 allele. Both alleles exhibited greatly
decreased RPM1-myc levels compared with wild-type
plants (Figure 6A). Curiously, hsp90.2-2 consistently
accumulated less RPM1-myc than hsp90.2-3. This sug-
gests that the partial penetrance phenotype of hsp90.2-2 is
not simply correlated to RPM1 levels.
Fig. 3. lra2 and ndr1 affect RPM1 function synergistically. Growth of
Pst DC3000(avrRpm1) in lra2;ndr1 double mutants with corresponding
controls, as in Figures 1 and 2. Both lra2 and ndr1 single mutants




Given the genetic interaction between rpm1 and
hsp90.2, we asked whether HSP90s could co-immunopre-
cipitate (co-IP) with RPM1-myc. We probed protein blots
of anti-myc IPs with an antibody raised against cytosolic
HSP90 from Pharbitis nil, which should detect all four
isoforms of cytosolic HSP90 in Arabidopsis (Krishna
et al., 1997). We successfully detected HSP90 in IPs
from RPM1-myc plant extracts, but not in IPs from rpm1
mutant extracts (Figure 6B). The HSP90 antibody failed
to detect a clear difference in protein levels between our
point mutants or insertion allele and wild-type (data
not shown). We therefore cannot ascertain whether the
HSP90 detected in our co-IPs is, or contains, HSP90.2. We
were unable to detect HSP90 in anti-RIN4 co-IPs, but
could co-IP RPM1-myc with anti-RIN4 from the same
extracts (data not shown). These data suggest that RIN4
and HSP90 interactions with RPM1 might be mutually
exclusive.
Fig. 4. Clustering of hsp90.2 mutations in the highly conserved N-terminal ATPase domain. (A) Alignment of the N-terminal ATPase domains of
HSP90 orthologs across diverse kingdoms, highlighting the residues mutated in our hsp90.2 alleles in red. Proteins compared: AtHSP90.2 (swissprot
id: HS82_ARATH), ScHSP82 (swissprot id: HS82_YEAST), DmHSP83 (swissprot id: HS83_DROME), HsHSP90a (swissprot id: HS9A_HUMAN)
and EcHptG (swissprot id: HTPG_ECOLI). (B) Hsp90.2 threaded over the structure of yeast HSP90 bound to ADP (center space ®lling structure)
viewed from two different angles. Residues that make direct interactions with ADP are in violet. The three residues mutated in our hsp90.2 alleles are
in yellow. Note that D80 makes direct contacts with ADP, and is mutated in hsp90.2-3.
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Disease signaling components RAR1 and SGT1
also associate with HSP90 in planta
RAR1 and SGT1 can be co-immunoprecipitated from
plant cell extracts (Azevedo et al., 2002). There are also
structural similarities between plant SGT1 and animal
proteins required for HSP90 assembly and function
(Dubacq et al., 2002; Garcia-Ranea et al., 2002; see
Discussion). These observations prompted us to explore
the physical relationships between RAR1, SGT1 and
HSP90.
We used antibodies raised against either RAR1 or SGT1
(Azevedo et al., 2002) to IP HSP90 from total plant
extracts. We found that anti-RAR1 is able to co-IP HSP90
from wild-type extracts, but not from rar1-20 extracts
(Figure 7A). Arabidopsis contains two SGT1 genes
encoding proteins of slightly different mobility (Austin
et al., 2002; ToÈr et al., 2002); both are detected by our
antisera under the IP conditions used. We found that anti-
SGT1 antibody is consistently able to co-IP HSP90 from
wild-type Col-0 and Ws-0 extracts (six out of six
experiments; Figure 7B). However, we detected no, or
only very low amounts, of HSP90 in anti-SGT1 IPs from
sgt1b extracts in multiple experiments (Figure 7B). This
suggests that the majority of HSP90 we detected is
associated with SGT1b, and that SGT1a may weakly
associate with HSP90. We invariably detected HSP90 in
IPs from sgt1a extracts (Figure 7B), strengthening this
conclusion. Thus, in our experimental conditions, there is
a preference for HSP90 to associate with SGT1b compared
with SGT1a, consistent with yeast two-hybrid data
(A.Takahashi and K.Shirasu, unpublished).
Fig. 5. RPM1 function is not compromised by an hsp90.2 insertion allele, and the hsp90.2-3 phenotype is independent of the conditional avrRpm1
expression system. (A) Bacterial growth assay with Pst DC3000(avrRpm1). The hsp90.2-5 (Salk 058553) T-DNA insertion allele displays a wild-type
response to Pst DC3000(avrRpm1). (B) In contrast, the hsp90.2-3 allele outcrossed from the transgenic, conditional avrRpm1 expression system is still
compromised for RPM1 function. This line, and controls, were spray infected with Pst DC3000(avrRpm1), and still exhibit symptoms intermediate to
a full loss-of-function rpm1 mutant.
Fig. 6. HSP90 interacts with RPM1. (A) hsp90.2 mutations severely
affect RPM1-myc accumulation. A 40 mg aliquot of total protein was
loaded and western blots were probed with anti-myc monoclonal
antibody. (B) Top: anti-myc and co-IPs demonstrate that HSP90
associates with RPM1-myc in planta. The relative amounts of protein
from the immune pellet and the total extracts are not equivalent. The
pellet is over-represented by 20-fold. This experiment is representative
of six independent replicates for RPM1-myc. Bottom: control showing
speci®city of IP reagents, and that RPM1-myc is extracted from
transgenic lines in appropriate mutant backgrounds under the conditions
used for the co-IP.
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Additionally, we detected HSP90 in anti-SGT1 IPs from
rar1 mutant extracts and in anti-RAR1 co-IPs from sgt1b
mutant extracts (Figure 7C). This suggests that RAR1 and
SGT1b can associate independently with HSP90. We
corroborated this ®nding in the converse experiment (IP
with anti-RAR1 and blot with anti-HSP90) using the null
rar1-20 allele (data not shown). We were, surprisingly,
able to detect consistently HSP90 from anti-RAR1 IPs in
rar1-21 mutant extracts (Figure 7C). The rar1-21 muta-
tion introduces a stop codon near the end of the CHORD I
domain (Tornero et al., 2002b), and consequently lacks the
CHORD II domain, known to be the RAR1±SGT1
interaction platform (Azevedo et al., 2002). While we
were unable to detect this small RAR1 fragment by direct
immunoblot, it appears suf®cient to IP HSP90, consistent
with two-hybrid interaction data presented elsewhere
(Takahashi et al., 2003).
Artifactual detection of HSP90 in immunoblots is a
concern, because it can represent up to 1±2% of total
cellular protein (Lai et al., 1984). We therefore used
several different antisera to test this, and found that none
of them could co-IP HSP90 (see Materials and methods),
thus suggesting strongly that our data represent speci®c
interactions.
Discussion
We provide genetic and biochemical data demonstrating
that RPM1 is a cytosolic HSP90 client. We demonstrate
that mutations in the Arabidopsis HSP90.2 can speci®cally
modulate RPM1 function. RPM1 accumulation is greatly
diminished in speci®c hsp90.2 missense mutants. We
provide pairwise co-IP data demonstrating interactions
between HSP90s and RPM1, RAR1 and SGT1. We show
that the HSP90 interaction with RAR1 does not require
SGT1, nor does the HSP90 interaction with SGT1 require
RAR1. Surprisingly, we did not ®nd an association of
HSP90s with RIN4, a protein clearly implicated in RPM1
and RPS2 function (Axtell and Staskawicz, 2003; Mackey
et al., 2003), suggesting that RIN4 and HSP90 association
with RPM1-myc might be mutually exclusive.
Our data suggest that RAR1, SGT1 and HSP90 may
work together to coordinate RPM1 function. The key
questions emerging from our work are: why do speci®c
hsp90.2 missense mutations result in diminution of RPM1
levels, and hence RPM1 function? Is the requirement for
HSP90 in RPM1 signaling indicative of a common
regulatory mechanism among the NB-LRR class of R
proteins? Do RAR1 and SGT1 act as cofactors for HSP90
in R protein signaling?
Genetic interactions support a quantitative
function for HSP90.2 in R-mediated disease
resistance
Our four hsp90.2 missense alleles are recessive and
signi®cantly reduce, but do not eliminate, RPM1 function.
They do not reproducibly affect any of the seven other R
functions tested. The hsp90.2 alleles exhibit non-allelic
non-complementation with rpm1, suggesting that the two
wild-type proteins act together. The fact that far less
steady-state RPM1-myc protein accumulates in two
hsp90.2 alleles provides a simple, dosage-based mechan-
istic explanation for this genetic observation.
Our results suggest that speci®c HSP90.2 missense
mutations alter RPM1 function. The four hsp90.2 alleles
reported here compare with 95 rpm1 alleles also identi®ed
in this screen (Tornero et al., 2002a). RPM1 is 926 amino
acids long, HSP90.2 is 699; thus target size cannot explain
this mutant ratio. Furthermore, the insertional hsp90.2-5
allele is viable, apparently null, and exhibited full RPM1
function. We assume that one of the other three cytosolic
HSP90s can compensate for the full loss of HSP90.2, as
observed in other systems (Borkovich et al., 1989). Thus,
our hsp90.2 alleles also prohibit functional compensation.
Signi®cantly, we did not recover alleles in any of the other
HSP90 genes as loss of RPM1 function mutants. Thus, our
hsp90.2 mutants are rare, and suggest a preferential
utilization of HSP90.2 in RPM1 accumulation and,
hence, in RPM1 function.
Importantly, a mutation exactly orthologous to hsp90-
2.3 (D80N) has been studied in yeast HSP90 (D79N). This
mutant yeast protein homodimerizes properly, and a wild-
type±mutant mixed dimer exhibits wild-type levels of
ATP hydrolysis (Richter et al., 2001). However, mutant
dimers are unable to bind or hydrolyze ATP (Obermann
et al., 1998; Panaretou et al., 1998), and in competition
assays are unable to interfere with ATP hydrolysis, even in
8-fold excess (Richter et al., 2001). Interestingly, a
Fig. 7. HSP90 associates with RAR1 and SGT1. (A) Hsp90 associates
with RAR1 in planta (top). The relative amounts of protein from the
co-IP pellet and the total extracts are not equivalent. The pellet is
over-represented by 10-fold. This experiment is representative of two
independent replicates. An extraction control is displayed below the
co-IP. (B) HSP90 displays an apparent preference for SGT1b over
SGT1a. (C) HSP90 interacts with RAR1 and SGT1b independently.
The N-terminal portion of RAR1 containing the CHORD I domain is
suf®cient for interaction with HSP90. The relative amounts of protein
from the co-IP pellet and the total extracts are not equivalent. The
pellet is over-represented by 10-fold. This experiment is representative
of three out of seven independent replicates for sgt1b and four out of
four independent replicates for sgt1a. Extraction controls beneath the
co-IPs demonstrate the differential mobilities of SGT1a and SGT1b and
the effect of the respective mutations.
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transcriptionally inducible yeast hsp90 (D79N) also
prevented phenotypic compensation by a wild-type,
constitutively expressed isoform (Panaretou et al., 1998).
This may explain how we identi®ed our mutants in plants
that normally contain four copies of cytosolic HSP90, as
well as suggesting that HSP90 isoforms might have non-
overlapping functions in Arabidopsis.
Our other two mutations, hsp90.2-1 (G95E) and
hsp90.2-2 (S100F), have not been identi®ed in screens in
other systems. Both are solvent exposed and adjacent to
ATP-interacting residues. It is possible that these muta-
tions also interfere with ATP binding. Altered ATP
binding/hydrolysis can also directly affect client protein
binding and release by HSP90, as well as the interaction of
HSP90 with its co-chaperones, thus de-stabilizing the
complex (Obermann et al., 1998; Panaretou et al., 1998).
Our evidence of both synergism (in pathogen growth
assays) and epistasis (in an HR assay) between hsp90.2
and ndr1 suggests that HSP90 and NDR1 act together in
the RPM1-dependent disease resistance response. A
requirement for HSP90.2 early in RPM1 signaling is
consistent with our proposal that it is part of, or required
for the assembly of, a poised RPM1 receptor complex.
These results suggest an interesting parallel with animal
innate immunity. NDR1 is a putative GPI-anchored
protein. In animal systems, HSP90 co-localizes with the
GPI-anchored protein CD14, and both act in the TLR4-
dependent innate immune response to lipopolysaccharide
(Trianta®lou et al., 2002). Also, HSP90 inhibitors prevent
the innate immune response activation by bacterial DNA
(Zhu and Pisetsky, 2001). We propose that NDR1 and
HSP90 function together, perhaps transiently, during
RPM1 signaling.
Could RAR1 and SGT1 function as HSP90 cofactors
in disease resistance pathways?
Several observations indicate that RAR1 and HSP90
function together in RPM1-dependent HR. We demon-
strated that RAR1 and SGT1 can associate with HSP90
in vivo. We noted a severe attenuation of RPM1-dependent
HR in hsp90.2 mutants and we found decreased RPM1-
myc stability in hsp90.2 mutants, two phenotypes
observed in rar1 plants (Tornero et al., 2002b). The
epistasis of hsp90.2 over ndr1 with respect to HR was also
observed with rar1;ndr1 double mutants assayed for
RPM1 function, and for the synergistic interaction of
rar1 and ndr1 in RPP7-mediated resistance (Tornero et al.,
2002b). These data are, in sum, consistent with RAR1 and
HSP90 acting together in both RPM1-dependent HR and,
possibly more broadly, in NB-LRR function. Our data are
further consistent with recent ®ndings demonstrating that
RAR1 and NDR1 contribute quantitatively to the function
of various NB-LRR R proteins (Muskett et al., 2002;
Tornero et al., 2002b).
Because an sgt1a;sgt1b double mutant is lethal in
Arabidopsis (A.Takahashi and K.Shirasu in preparation),
it is impossible to determine if SGT1 isoforms have
overlapping function in RPM1 signaling. Recent gene
silencing experiments corroborate a role for HSP90 in the
function of several R genes that also require SGT1 and
RAR1 for their function (Lu et al., 2003). Structural
modeling also supports the contention that RAR1 and
SGT1 might act as cofactors of HSP90 (Shirasu and
Schulze-Lefert, 2003). SGT1 and RAR1 homologs in
animals have predicted structural homology to the HSP90
partner protein, p23 (Dubacq et al., 2002; Garcia-Ranea
et al., 2002; see Supplementary ®gure 3). Additionally, the
TPR domain of SGT1 shares structural homology with
other HSP90 partner proteins including HOP/STI1
(Garcia-Ranea et al., 2002).
We propose that RAR1 and HSP90 normally not only
act to maintain RPM1 in a signal competent conformation,
but also stabilize RPM1 against degradation. This is
reminiscent of the assembly of activation-competent
steroid receptors with an HSP90 isoform homodimer and
various co-chaperones (Pratt and Toft, 2003). HSP90
binding to the steroid receptor is not suf®cient to render the
receptor competent; cofactor binding and continual ATP
turnover are required to maintain the steroid-binding cleft
in a receptive conformation (Pratt and Toft, 2003). Further
conformational change accompanies ligand binding.
Inhibition of ATP binding and/or turnover in our
hsp90.2 mutants should result in a locked HSP90
conformation, bound to RPM1 but unable to hold it
appropriately, thus leading to RPM1 disappearance. This
would mimic the effect on client proteins observed after
treatment with the ATP-binding inhibitor geldanamycin in
other systems. RPM1 instability is consistent with results
showing that HSP90 can rapidly shut off transcriptional
responses by binding transcription factors and causing
their degradation (Freeman and Yamamoto, 2002). Steroid
receptor levels, like RPM1 (Boyes et al., 1998), drop after
signaling (Lange et al., 2000; Wallace and Cidlowski,
2001).
Evidence for a second HSP90 function in protein
stability is also emerging. First, human SKP2, a member
of the SCF complex, is able to co-immunoprecipitate
HSP90b in mouse NIH-3T3 cells (Lyapina et al., 1998).
Degradation of HSP90 client proteins, triggered by either
geldanamycin treatment or overexpression of the E3 ligase
CHIP, can be inhibited by the addition of proteasome
inhibitors (Whitesell and Cook, 1996; Segnitz and
Gehring, 1997; Connell et al., 2001). However, full
steroid binding is not recovered in these experiments,
also suggesting two functions for HSP90. One, reversible
by lactacystin, is required for degradation, and another, not
completely reversed by lactacystin, is required to mold a
steroid-binding complex. Initiation of RPM1 function
leads to RPM1 degradation (Boyes et al., 1998), perhaps
involving SGT1 that is ®rst recruited to an HSP90±RPM1
complex and then guides RPM1 to the proteasome. RAR1
may normally block this conversion, perhaps in conjunc-
tion with (or antagonistically to) SGT1. This notion is
consistent with our ®ndings that RAR and SGT1 do not
require each other to associate with HSP90.
A model where HSP90, in association with RAR1 and
SGT1, controls levels of properly poised R protein
complexes is consistent with the two functions of HSP90
discussed aboveÐconformational molding and traf®cking
to the proteasome. Because of both R protein sequence
polymorphism and the possibility that R proteins might
associate with additional cellular proteins, one could
expect differential functional requirements for mainten-
ance of this poised complex. For example, we also could
co-IP HSP90 with anti-hemagglutinin (HA) monoclonal
antibody detecting an RPS2-HA fusion (data not shown),
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suggesting that at least one other NB-LRR protein can
interact with a cytosolic HSP90. However, we observed no
change in RPS2 function in our mutants. This model is
consistent with the fact that RPM1-mediated HR is very
fast compared with others, including RPS2, and that
RPM1 is degraded following triggering, unlike RPS2
(Axtell and Staskawicz, 2003). A requirement for a ®nely
tuned conformational poise in NB-LRR R protein function
was suggested recently using split Rx molecules (Moffett
et al., 2002).
We thus favor an overall model whereby different
NB-LRR R proteins, perhaps in association with the
cellular proteins they guard, are kept in active sentinel
mode by varying degrees of dynamic re-shaping and
maintenance of appropriate steady-state levels driven by
HSP90, RAR1 and SGT1. This model can encompass a
continuous quantitative function for HSP90 in both the
assembly of conformationally charged R protein com-




Transgenic Arabidopsis ecotype Columbia (Col-0) (line a11) and rpm1-1
(line a11r) containing estradiol-inducible avrRpm1 have been described
in Tornero et al. (2002a). Mutant lines used (all in Col-0 unless noted)
were ndr1-1 (Century et al., 1997), rar1-20; a null allele, originally pbs2
(Warren et al., 1999), rar1-21 (Tornero et al., 2002b), rps2-101C
(Mindrinos et al., 1994), rps5-2 (Warren et al., 1998), ecotype RLD
(Hinsch and Staskawicz, 1996) as an rps4 mutant control, sgt1a (T-DNA
insertion in Ws-0 ecotype; A.Takahashi and K.Shirasu, in preparation),
and sgt1b (edm1-1; ToÈr et al., 2002). We constructed double mutants of
hsp90.2 and rpm1-1 by identifying F2 individuals susceptible to Pst
DC3000(avrRpm1) which were molecularly heterozygous for rpm1-1, yet
did not give rise to resistant offspring in the next generation. The F3s from
such a line were then selected for a homozygous rpm1-1 mutant. These
lines were con®rmed after identi®cation of the hsp90.2 mutations using
PCR-based markers. A similar procedure was used for creation of hsp90.2
and ndr1 double mutants. A homozygous insertion in the SALK tDNA
insertion line 058553 was identi®ed by molecular analysis of a
segregating pool. The insertion site was con®rmed by sequencing of
T-DNA-speci®c product. Primer sequences for selection of mutations are
available on request.
Bacterial strains, inoculation and growth quanti®cation
Pst DC3000 derivatives containing pVSP61 (empty vector), avrRpm1,
avrB, avrRpt2, avrPphB or avrRps4 were maintained as described (Ritter
and Dangl, 1996). Plant inoculations and counting of the bacteria were
performed as described (Tornero and Dangl, 2001). Where indicated,
high concentrations of bacteria (OD600 = 0.075, 3.75 3 107 c.f.u./ml)
were in®ltrated into the bottom part of the leaf with a blunt syringe to test
for the induction of HR.
Estradiol induction
Two-week-old plants grown under short day (8 h) conditions were
sprayed with 0.02% silwet L-77 (CKWitco Corporation) and 10 mM
b-estradiol (Sigma E 8875) in distilled water from a 10 mM b-estradiol
stock dissolved in 100% ethanol (Tornero et al., 2002a).
Mapping and tests for disease symptoms
Rough mapping was performed by crossing hsp90.2 mutants and
Landsberg erecta (La-er). F2s were tested for lra2-like disease symptoms.
One- to three-week-old F2 plants were sprayed with a 10 mM MgCl2
suspension containing PstDC3000(avrRpm1) at a concentration of
OD600 = 0.1 (5 3 107 c.f.u./ml) with 0.02% silwet L-77, covered with
a clear lid for 4 h, and assessed for chlorosis and other symptoms of
P.syringae infection 4±6 days later under short day conditions. c2
analyses showed that all mutations were recessive: lra2-1: 480 wt, 612
mutant c2 = 3.843; P = 0.05; lra2-2: 217 wt, 89 mutant c2 = 2.723,
P = 0.099; lra2-3: 457 wt, 155 mutant c2 = 0.035, P = 0.85. Susceptible
F2 individuals were allowed to self and were con®rmed in the F3
generation. DNA (Ausubel et al., 1987) from 41 of these individuals was
used in PCR ampli®cation of known PCR-based molecular markers
(www.arabidopsis.org) to obtain approximate mapping positions. This
interval was re®ned using molecular markers we developed (available
upon request). We used DNA from 939 susceptible F2 individuals to
de®ne a 52 kb interval on P1 clone MDA7. The ~52 kb LRA2 interval lies
between a T/A polymorphism at position 551 (Jander et al., 2002) and the
published CAPS marker MDA7 (www.arabidopsis.org) at position 52 632
(C/A) relative to the published sequence for P1 clone MDA7 (Kaneko
et al., 1998). Independent mapping of the lra2-2 (195 susceptible
individuals) and lra2-3 (312 susceptible individuals) alleles showed
similar linkage. All mutations where con®rmed by sequencing of both
DNA strands.
Alignments and threading analysis
Protein alignments of HSP90 N-termini were made using Align X [a
component of Vector NTI Suite 7.1; Informax, Inc. (Frederick, MD)].
This program uses CLUSTALW to make alignments. Parameters used
were: gap opening penalty = 10, gap extension penalty = 0.05, gap
separation penalty range = 8, percentage identity for alignment delay = 40,
and hydrophobic residue gap = GPSNQEKR.
The sequences of AtSGT1a and AtSGT1b were submitted to the
threading Meta server [META] (http://bioinfo.pl/meta/) to identify
structural templates for homology modeling. The meta server accessed
the following fold recognition servers and reported the consensus:
bioinbgu [BIOINBGU], 3D-PSSM [3D-PSSM], GenTHREADER
[GENTHREADER], FUGUE [FUGUE] and Sam-T99 [SAMT99]. The
meta server identi®ed the crystal structure of the TPR1 domain of Hop
(PDB ID 1elw) as a structural template for residues 1±115 of AtSGT1a,
and the crystal structure of the human co-chaperone P23 (PDB ID 1ejf) as
a structural template for residues 156±237 of AtSGT1a. Models of the
P23 and TPR domains were built using the Modeler module of
the InsightII molecular modeling system from Accelrys Inc. (www.
accelrys.com). Figures were created with SPOCK.
Protein blots and co-immunoprecipitations
For detection of RPM1-myc in hsp90.2-2 and hsp90.2-3, we introgressed
these mutants into plants expressing RPM1-myc from the native RPM1
promoter (Boyes et al., 1998) as described in Tornero et al. (2002b). Total
protein was extracted in 50 mM Tris±HCl pH 8.0, 1% SDS, 1 mM EDTA,
1 mM 2-mercaptoethanol and 13 plant protease inhibitor cocktail
(Sigma). For immunodetection, 40 mg protein samples were electro-
phoresed on 8% SDS±polyacrylamide gels. Western blots were
performed using standard methods and detected with ECL+ (Amersham).
For co-immunoprecipitations, tissue was ®rst ground in liquid nitrogen
with a mortar and pestle. This material was then homogenized by
alternate rounds of Polytron (Kinematica) and glass douncer (Kontes
Glass Company) in 2 ml of sterile buffer 20 mM Tris±HCl pH 8.0, 0.33 M
sucrose,10 mM EDTA, 5 mM dithiothreitol (DTT) and 13 plant protease
inhibitor cocktail (Sigma) per 1 g of tissue. Debris was removed by
centrifugation at 5000 g for 40 min at 4°C. A 1.5 ml aliquot of this
supernatant was ®rst pre-cleared by adding 50 ml of protein G±agarose
(Boehringer Mannheim) and incubated at 4°C for 60 min on an orbital
shaker. The cleared supernatant was then removed and combined with
one of the following: 5 ml of the anti-RAR1 (Muskett et al., 2002)
antibody, 5 ml of anti-SGT1 (Azevedo et al., 2002) antibody, 30 ml of a re-
suspended anti-HA Af®nity Matrix (3F10, Roche) or 30 ml of a re-
suspended anti-c-Myc agarose (9E10, Santa Cruz Biotechnology). This
was followed by incubation at 4°C for 2 h. A 50 ml aliquot of protein
G±agarose was then added to the reactions containing the anti-RAR1 and
anti-SGT1 antibodies. All reactions were then rolled at 4°C overnight.
Beads were pelleted at 1000 g for 5 min. This was followed by four
washes in 1.5 ml of 50 mM HEPES pH 7.4, 100 mM NaCl, and 10 mM
EDTA pH 8.0. Bound proteins were eluted with 50 ml of sample buffer
and run on an 8% polyacrylamide gel, and probed with a polyclonal
antibody raised against the C-terminal portion of P.nil HSP90 (Krishna
et al., 1997).
HSP90 was not detected in control immunoprecipitations with four
different antibodies, three of which do immunoprecipitate HSP90 via
RPM1-myc, RAR1 or SGT1b. Thus, HSP90 is not non-speci®cally
sticking to protein A/G±agarose beads or other matrix reagents.
Furthermore, we used antibodies to actin (soluble), ascorbate peroxidase
(soluble), BiP (soluble and endoplasmic reticulum), toposiomerase II
(nuclear), RD28 (intergral plasma membrane) (Daniels et al., 1994) and
Tip (tonoplast intrinsic protein). None of these co-immunoprecipitated
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HSP90. The absence of HSP90 in these IPs (data not shown) argues for
the speci®city of our co-IP data.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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